Rossari Biotech approves capacity expansions at key subsidiaries
Rossari Biotech will expand capacity at its subsidiaries Unitop and Tristar. Unitop plans to add 18,500 MTPA by Q4 FY26 with an investment of $9.24 million, aimed at supporting new product lines and boosting competitiveness. Tristar will add 3,600 MTPA to its 15,000 MTPA capacity with $2.4 million to upgrade equipment, enhance efficiency, and cut maintenance costs.
Rossari Biotech will expand capacity at its subsidiaries Unitop and Tristar.
Unitop plans to add 18,500 MTPA by Q4 FY26 with an investment of $9.24 million, aimed at supporting new product lines and boosting competitiveness.
Tristar will add 3,600 MTPA to its 15,000 MTPA capacity with $2.4 million to upgrade equipment, enhance efficiency, and cut maintenance costs.
